EP4378461A3 — Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents
Assigned to University of California · Expires 2024-09-11 · 2y expired
What this patent protects
A submicron structure comprisinga silica body defining a plurality of pores that are suitable to receive molecules therein, and having a surface, anda phospholipid bilayer coating the surface,wherein said submicron structure has a maximum dimension of less than one micron, andwhe…
USPTO Abstract
A submicron structure comprisinga silica body defining a plurality of pores that are suitable to receive molecules therein, and having a surface, anda phospholipid bilayer coating the surface,wherein said submicron structure has a maximum dimension of less than one micron, andwherein the phospholipid bilayer stably seals the plurality of pores; andwherein the submicron structure is a member of a monodisperse population of submicron structures.
Drugs covered by this patent
- Camptosar (Irinotecan Hydrochloride) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.